NASDAQ:CERN - Nasdaq - US1567821046 - Common Stock
Overall CERN gets a fundamental rating of 2 out of 10. We evaluated CERN against 36 industry peers in the Health Care Technology industry. Both the profitability and financial health of CERN have multiple concerns. CERN is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.99% | ||
ROE | 15.08% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 15.88% | ||
PM (TTM) | 10.15% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Altman-Z | 7.44 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.79 | ||
Quick Ratio | 1.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 27.28 | ||
Fwd PE | 22.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 17.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.14% |
94.92
-0.05 (-0.05%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.14% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 27.28 | ||
Fwd PE | 22.66 | ||
P/S | 4.81 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 7.14 | ||
P/tB | N/A | ||
EV/EBITDA | 17.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.99% | ||
ROE | 15.08% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | 15.88% | ||
PM (TTM) | 10.15% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.41 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.79 | ||
Quick Ratio | 1.77 | ||
Altman-Z | 7.44 |